High insulin prices spur federal lawsuit against three pharmacy benefit managers
The FTC is suing big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
The FTC is suing big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.